
Sign up to save your podcasts
Or


This podcast discusses significant advancements in digital health and biotechnology, highlighting Samsung's acquisition of Xealth to integrate wearable health data with electronic health records, thereby intensifying the competition among tech giants like Apple and Google in clinical workflow integration. The text also details JMDC's new AI-powered "Pep Up Sleep" service aimed at visualizing sleep quality to reduce healthcare costs and notes research on improving calorie estimation accuracy through contextual metadata for food photos. Furthermore, the sources touch upon a biotech venture focused on infertility treatments and present HAL's recognition as a unique device inducing neuroplasticity for comprehensive therapeutic effects, especially in spinal cord injuries. The combined information illustrates a rapidly evolving landscape where technology is increasingly being leveraged for health monitoring, clinical integration, and innovative treatments.
This collection of articles explores recent innovations and challenges within the healthcare technology sector. OPERe's "Pokesapo" service is highlighted for its successful funding round and unique approach to patient-provider communication, leveraging existing hospital materials and the LINE platform to streamline information sharing. The text also discusses HELTEC's new fall risk assessment feature for its walking analysis device, emphasizing its diagnostic capabilities. Furthermore, it addresses the abrupt termination of the partnership between Novo Nordisk and Hims & Hers, detailing concerns over deceptive marketing and the sale of unapproved GLP-1 medications. Finally, the collection introduces Beijing University's groundbreaking "NanoFLUID" electronic bandage, which promises more efficient drug delivery to internal organs through electrical charges.
This compilation of news and insights covers various health and technology topics, primarily focusing on medical advancements and wellness information. The sources discuss dietary impacts on liver health, specifically highlighting the dangers of sugary liquid-based drinks and explaining how fructose in liquid form can damage the liver. It also explores the increasing incidence of fatty liver disease in lean individuals, attributing it to low muscle mass. Furthermore, the text addresses sleep apnea, detailing its high prevalence, underdiagnosis, and an innovative new tongue nerve electrical stimulation treatment. Finally, the sources touch upon Google DeepMind's AlphaGenome AI model, designed for high-resolution analysis of long DNA sequences, particularly focusing on non-coding regions, and mentions the emergence of AI-powered tools for medical literature analysis and AI-driven severity assessment for atopic dermatitis.
This podcastFujifilm uses AI to generate diagnostic findings, reducing the burden by 30 million cases per year. Is it true that humans are necessary to take responsibility? explores the increasing integration of artificial intelligence (AI) in healthcare, highlighting several key developments. Fujifilm plans to implement AI for generating medical image reports by 2028, aiming to significantly reduce the burden on doctors by automating report creation. The article also discusses the societal implications of AI in traditionally human-centric roles, drawing parallels to the historical shift in elevator operation from human-driven to automated, and questions the long-held belief that human responsibility is always necessary. Furthermore, the source details advancements in AI-powered communication and patient support, such as AI assistants for pharmacies and AI chatbots for cancer patients, suggesting that even emotional support may eventually be augmented or handled by AI. Finally, it touches on AI's role in streamlining administrative tasks, like voice-to-text medical record input, and the growth of AI in digital physical and mental health therapy, indicating a broader shift towards AI-driven solutions across various healthcare sectors.
This compilation of news and insights from Kazutaka Yoshinaga offers a comprehensive look into the evolving landscape of medical healthcare in Japan and beyond. It highlights Kakehashi's significant Series D funding and their Musubi system's rapid market dominance in electronic prescription records, showcasing their expansion into patient monitoring via LINE and integrating healthcare services with healthy foods. The source also discusses innovations in AI for medical prognostics like the FaceAge deep learning model for cancer patients and Open Evidence, an AI-powered search tool for clinical queries, which is gaining traction over traditional resources like UpToDate. Furthermore, it covers Somnee's successful Series A funding for its wearable sleep technology that leverages EEG and AI, and concludes with the author's contribution to a medical journal on organizing medical information.
This episode presents an overview of recent developments in the Japanese healthcare and technology sectors. It highlights Kirin's award-winning "Premedi" service, which uses AI to predict demand for less common pharmaceuticals and employs a delivery and buyback model to minimize pharmacy losses. The article also mentions Panasonic's entry into femtech, a company called Medii adding AI to its online doctor consultation service, SCUEL offering data on upcoming clinic openings, and Hinge Health's significant IPO focusing on musculoskeletal health programs.
This week in medical news, OpenAI announced HealthBench, a new way to evaluate medical AI models that suggests large language models (LLMs) may soon surpass specialists, though LLM-supported doctors currently perform similarly to standalone LLMs. In another development, AI Scientist, a multi-agent system, discovered a promising drug candidate for a major cause of blindness, demonstrating a closed-loop AI approach to scientific discovery. Simultaneously, a "Don't Die" movement is gaining traction in Silicon Valley focused on radical life extension and utilizing services like genetic testing kits, while traditional weight loss programs are facing challenges with the bankruptcy of WW International amidst the rise of GLP-1 medications.
This podcast provides an overview of the current state of Digital Therapeutics (DTx), focusing on the differences in adoption and regulatory landscapes between the United States and Japan. It explores the challenges and opportunities for DTx, discussing factors like drug pricing, insurance reimbursement, regulatory approval processes, and the perspectives of both doctors and patients.
The podcast also examines the potential for DTx in preventive medicine and different business models for its implementation.
This PodCast discusses Medley's Q1 2025 financial results. In particular, it describes the 37% YoY increase in revenues, driven primarily by growth in the Human Resources Platform segment. The report also details the newly launched “job medley spot” and the strategic use of generative AI in the healthcare platform. The author also expresses his personal opinion that the introduction of medical AI agents may be an effective way to utilize generative AI.
This podcast discusses the full year 2024 financial results and outlook for M3, a technology company in the healthcare sector. It is noted that while sales have remained strong, operating profit margins have declined. In particular, the mainstay medical platform and clinical trial businesses experienced declines in both sales and profits due to the end of special demand. On the other hand, the staffing and hospital management support businesses are growing, and in the hospital management support business in particular, the introduction of M3 DigiCal is proving to be a strong success. The report also analyzes that the standardized electronic medical record promoted by the government will not have a significant impact on M3's business, and mentions the company's entry into corporate services through the acquisition of Ewell.
From the publisher's feed